Quarterly report pursuant to Section 13 or 15(d)

EMPLOYEE AND DIRECTOR BENEFITS

v3.4.0.3
EMPLOYEE AND DIRECTOR BENEFITS
 3 Months Ended
Mar. 31, 2016
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
EMPLOYEE AND DIRECTOR BENEFITS
NOTE 7 - EMPLOYEE AND DIRECTOR BENEFITS
 
Stock Options
 
At March 31, 2016, the Company had stock incentive plans as described below. The compensation cost that has been charged to earnings for the plans was approximately $343,000 and $301,000 for the three months ended March 31, 2016 and 2015, respectively.
 
The Company’s 2005 Amended and Restated Stock Incentive Plan allows for the grant of stock options to purchase up to 3,075,000 shares of the Company’s common stock. The Company’s 2009 Amended and Restated Stock Incentive Plan authorizes the grant of up to 2,775,000 shares and allows for the issuance of Stock Appreciation Rights, Restricted Stock, Stock Options, Non-stock Share Equivalents, Performance Shares or Performance Units. Both plans allow for the grant of incentive stock options and non-qualified stock options, and awards are generally granted with an exercise price equal to the fair market value of the Company’s common stock at the date of grant. The maximum term of the options granted under the plans is ten years.
 
The Company estimates the fair value of each stock option award using a Black-Scholes-Merton valuation model which incorporates the assumptions noted in the following table. Expected volatilities are based on an index of southeastern United States publicly traded banks. The expected term for options granted is based on the short-cut method and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U. S. Treasury yield curve in effect at the time of grant.
   
 
 
2016
 
2015
 
Expected volatility
 
 
29.00
%
 
24.00
%
Expected dividends
 
 
0.60
%
 
0.75
%
Expected term (in years)
 
 
6 years
 
 
6 years
 
Risk-free rate
 
 
1.92
%
 
1.71
%
 
The weighted average grant-date fair value of options granted during the three months ended March 31, 2016 and March 31, 2015 was $11.53 and $7.61, respectively.
 
The following table summarizes stock option activity during the three months ended March 31, 2016 and March 31, 2015:
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Weighted
 
Average
 
 
 
 
 
 
 
Average
 
Remaining
 
 
 
 
 
 
 
Exercise
 
Contractual
 
Aggregate
 
 
 
Shares
 
Price
 
Term (years)
 
Intrinsic Value
 
 
 
 
 
 
 
 
 
(In Thousands)
 
Three Months Ended March 31, 2016:
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2016
 
 
1,249,417
 
$
13.32
 
 
6.3
 
$
42,743
 
Granted
 
 
99,000
 
 
38.21
 
 
9.8
 
 
-
 
Exercised
 
 
(205,500)
 
 
8.53
 
 
4.6
 
 
7,372
 
Forfeited
 
 
(4,500)
 
 
39.04
 
 
9.3
 
 
24
 
Outstanding at March 31, 2016
 
 
1,138,417
 
 
16.24
 
 
6.7
 
$
32,058
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at March 31, 2016
 
 
391,418
 
$
9.47
 
 
5.2
 
$
13,672
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended March 31, 2015:
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2015
 
 
1,622,917
 
$
9.38
 
 
5.9
 
$
38,256
 
Granted
 
 
85,500
 
 
30.77
 
 
9.9
 
 
-
 
Exercised
 
 
(215,500)
 
 
6.19
 
 
3.1
 
 
5,774
 
Forfeited
 
 
-
 
 
-
 
 
-
 
 
-
 
Outstanding at March 31, 2015
 
 
1,492,917
 
 
11.06
 
 
6.3
 
$
32,737
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at March 31, 2015
 
 
383,418
 
$
8.64
 
 
4.5
 
$
9,335
 
 
As of March 31, 2016, there was $2,651,000 of total unrecognized compensation cost related to non-vested stock options. The cost is expected to be recognized on the straight-line method over the next 2.6 years.
 
Restricted Stock
 
The Company has issued 241,588 shares of restricted stock to certain employees. The value of restricted stock awards is determined to be the current value of the Company’s stock at the time of grant, and this total value will be recognized as compensation expense over the vesting period, which is five years from the date of grant. As of March 31, 2016, there was $633,000 of total unrecognized compensation expense. The expense is expected to be recognized evenly over the remaining 2.3 years of the restricted stock’s vesting period.